Chronic lymphocytic leukemia
Would you like to receive a message when there is new research on Chronic Lymphocytic Leukemia? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, a sentence above each publication explains what was studied — and you'll receive a notification as soon as there is new research about Chronic lymphocytic leukemia. View what Premium costs.
Publications and studies (1769)
- Redirecting T-cell Activity with Anti-BCMA/Anti-CD3 Bispecific Antibodies in Chronic Lymphocytic Leukemia and Other B-cell Lymphomas. (2022/05/09) ♡
- Ocular adnexal lymphoma: A single-institution retrospective study. (2022/04/18) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. The Sandwich Sign in Small Lymphocytic Lymphoma. (2022/04/01) ♡
- Humoral Responses After SARS-CoV-2 mRNA Vaccination and Breakthrough Infection in Cancer Patients. (2022/04/01) ♡
- Secondary Hypogammaglobulinemia in Patients with Chronic Lymphocytic Leukemia Receiving Ibrutinib Therapy. (2022/04/01) ♡
- Elucidation of Focal Adhesion Kinase as a Modulator of Migration and Invasion and as a Potential Therapeutic Target in Chronic Lymphocytic Leukemia. (2022/03/22) ♡
- High-risk subtypes of chronic lymphocytic leukemia are detectable as early as 16 years prior to diagnosis. (2022/03/10) ♡
- Deep latent space fusion for adaptive representation of heterogeneous multi-omics data. (2022/03/10) ♡
- Bendamustine-induced rash is associated with a favorable prognosis in patients with indolent B-cell lymphoma. (2022/03/09) ♡
- Preclinical Validation of Tumor-Penetrating and Interfering Peptides against Chronic Lymphocytic Leukemia. (2022/03/07) ♡
- Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. Continuous treatment with Ibrutinib in 100 untreated patients with TP53 disrupted chronic lymphocytic leukemia: A real-life campus CLL study. (2022/03/01) ♡
- Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. Zanubrutinib for treatment-naïve and relapsed/refractory chronic lymphocytic leukaemia: long-term follow-up of the phase I/II AU-003 study. (2022/03/01) ♡
- The Two-Step Allogeneic Stem Cell Transplantation Approach Results in Rapid Engraftment and Excellent Outcomes in Patients with Lymphoid Malignancies. (2022/03/01) ♡
- Combinatorial antigen targeting strategies for acute leukemia: application in myeloid malignancy. (2022/03/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Chronic lymphocytic leukemia with a transient atypical T-cell proliferation raising concern for T-cell lymphoma. (2022/03/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Optic Perineuritis Presenting as the Initial Manifestation of Central Nervous System Involvement in Rai Stage 0 Chronic Lymphocytic Leukemia. (2022/03/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Leukemia Cutis Mimicking Granulomatous Rosacea at the Onset of Chronic Lymphocytic Leukemia. (2022/03/01) ♡
- The Influence of Underlying Disease on Rituximab Pharmacokinetics May be Explained by Target-Mediated Drug Disposition. (2022/03/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Emerging data for venetoclax in chronic lymphocytic leukemia. (2022/03/01) ♡
- A bis-pyridinium fullerene derivative induces apoptosis through the generation of ROS in BCR-ABL-positive leukemia cells. (2022/02/05) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Serologic response following SARS-COV2 vaccination in patients with cancer: a systematic review and meta-analysis. (2022/02/05) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. CD99 in malignant hematopoiesis. (2022/02/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Current Treatment of Chronic Lymphocytic Leukemia: The Diminishing Role of Chemoimmunotherapy. (2022/02/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. SARS-CoV-2 specific cellular response following COVID-19 vaccination in patients with chronic lymphocytic leukemia. (2022/02/01) ♡
- Cellular Therapy Advances in Chronic Lymphocytic Leukemia and Richter's Syndrome. (2022/02/01) ♡
- The Effect of Dietary Intervention With High-Oleocanthal and Oleacein Olive Oil in Patients With Early-Stage Chronic Lymphocytic Leukemia: A Pilot Randomized Trial. (2022/01/21) ♡
- Benefits of Chimeric Antigen Receptor T-Cell Therapy for B-Cell Lymphoma. (2022/01/20) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Case Report: Long-Term Survival of a Dog With Chronic Lymphocytic Leukemia Treated With Chlorambucil, Prednisolone, and Imatinib. (2022/01/17) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. "Double-Hit" Chronic Lymphocytic Leukemia, Involving the TP53 and MYC Genes. (2022/01/13) ♡
- Low-dose ionizing radiation exposure and risk of leukemia: results from 1950-1995 Chinese medical X-ray workers' cohort study and meta-analysis. (2022/01/10) ♡
- Notch2 Increases the Resistance to Venetoclax-Induced Apoptosis in Chronic Lymphocytic Leukemia B Cells by Inducing Mcl-1. (2022/01/06) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Bruton Tyrosine Kinase Inhibitors in B-Cell Malignancies: Their Use and Differential Features. (2022/01/01) ♡
- Zilovertamab Vedotin Targeting of ROR1 as Therapy for Lymphoid Cancers. (2022/01/01) ♡
- The C-terminal tail of ribosomal protein Rps15 is engaged in cytoplasmic pre-40S maturation. (2022/01/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. A 67-Year-Old Male Patient With COVID-19 With Worsening Respiratory Function and Acute Kidney Failure. (2022/01/01) ♡
- Nutritional status of patients with lymphoproliferative neoplasms before and after the first-line treatment. (2022/01/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. [Bruton tyrosine kinase inhibitors. What does the oncohematologist and the cardiologist need to know?]. (2022/01/01) ♡
- Characterization of Chronic Lymphocytic Leukemia Immunoglobulin Rearrangements from Partial Read Sequencing. (2022/01/01) ♡
- Efficacy of Front-Line Ibrutinib and Rituximab Combination and the Impact of Treatment Discontinuation in Unfit Patients with Chronic Lymphocytic Leukemia: Results of the Gimema LLC1114 Study. (2021/12/31) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. MRD in CLL: some answers, many questions. (2021/12/30) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Persistent SARS-CoV-2 infection in patients with secondary antibody deficiency: successful clearance following combination casirivimab and imdevimab (REGN-COV2) monoclonal antibody therapy. (2021/12/30) ♡
- Healthcare Utilization and Comorbidity in Chronic Lymphocytic Leukemia. (2021/12/30) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Hyperleukocytosis and Pseudohyperkalemia in a Patient With Severe SARS-COVID 19 Unmasks Chronic Lymphocytic Leukemia. (2021/12/30) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Targeted Treatment of Chronic Lymphocytic Leukemia: Clinical Utility of Acalabrutinib. (2021/12/29) ♡
- Retracted publicationiThis research has been withdrawn by science itself, for example due to a flaw in the method or unreliable data. Do not use it as support and do not discuss it as evidence. miR-10b-5p Suppresses the Proliferation and Invasion of Primary Hepatic Carcinoma Cells by Downregulating EphA2. (2021/12/29) ♡
- Venetoclax for Children and Adolescents with Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma. (2021/12/29) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The Role of Neutrophils in the Pathogenesis of Chronic Lymphocytic Leukemia. (2021/12/29) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Histone Methyltransferase SETD2 in Lymphoid Malignancy. (2021/12/28) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Infective Endocarditis-Like Presentation of Felty Syndrome: A Case Report. (2021/12/26) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. The Difficult-to-Treat del 17 p Patient-A Case Report in Chronic Lymphocytic Leukemia. (2021/12/24) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.